3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Leukemia, Promyelocytic, Acute
20
Leukemia, Myeloid, Acute
20
Myelodysplastic Syndromes
9
Multiple Myeloma
9
Leukemia
8
Pancreatic Neoplasms
4
Neoplasm Metastasis
4
Uterine Cervical Neoplasms
3
Neuroblastoma
3
Lung Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Thrombocytopenia
2
Prostatic Neoplasms
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Pathologic Complete Response
2
Neoplasms, Plasma Cell
2
Myeloproliferative Disorders
2
Myelodysplastic-Myeloproliferative Diseases
2
Melanoma
2
Lymphoma, T-Cell, Cutaneous
2
Lymphoma, Non-Hodgkin
2
Lymphoma
2
Leukemia, Myelomonocytic, Chronic
2
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
2
Hodgkin Disease
2
Hematologic Neoplasms
2
Congenital Abnormalities
2
Colorectal Neoplasms
2
Breast Neoplasms
2
Blast Crisis
2
Interventions
Cisplatin
25
Cetuximab
12
Radiotherapy
11
Docetaxel
11
Fluorouracil
9
Carboplatin
9
Surgical Procedures, Operative
8
Radiotherapy, Intensity-Modulated
8
pembrolizumab
7
Magnetic Resonance Spectroscopy
7
Radiation
6
Surveys and Questionnaires
5
Specimen Handling
5
Drug Therapy
5
toripalimab
4
Standard of Care
4
Celecoxib
4
1,2-diaminocyclohexaneplatinum II citrate
4
X-Rays
3
Platinum
3
Paclitaxel
3
Nutritional Status
3
Interviews as Topic
3
Hydroxyurea
3
Counseling
3
Biopsy
3
130-nm albumin-bound paclitaxel
3
Taxes
2
Resistance Training
2
Psychiatric Rehabilitation
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Laryngeal Neoplasms
×
Tretinoin
×
Clear all
NCT06706401
2026-04-24
LYSARI
Centre Leon Berard
Phase 3
Recruiting
460 enrolled